GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above - PRNewswire

GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above  PRNewswire

LONDON and PHILADELPHIA, April 26, 2019 /PRNewswire/ -- GSK today announced that the US Food and Drug Administration (FDA) has approved, under ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases